~~<i id='D85ABB0DAC'><strike id='D85ABB0DAC'><tt id='D85ABB0DAC'><pre id='D85ABB0DAC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：Wikipedia 2025-09-30 22:27:10 - browse：53

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

hotspot

explore

hotspot

focus

RichardEvansSchultesintheCerroCampanamountainsinColombia,inJune1943.TheEstateofRichardEvansSchultes/

WSS

Dario to buy mental health app maker Twill in cash and stock deal

Why palliative psychiatry is worth discussing

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

NIH study of ME/CFS points to clear biological hallmarks

Doctors are clamoring for more clarity on Paxlovid prescribing

With heat waves through August, officials warn of health risks

entertainment

entertainment

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Failure, not just success, should guide future doctors

At least 13 dead in Texas as scorching temps continue

Paxlovid rebound happens. Why and to whom are still a mystery

Guidelines to prevent youth baseball injuries need more muscle

R1 RCM gets $5.8 billion buyout offer from private equity firm

Dobbs anniversary: the lost opportunity of abortion as health care

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

explore

Doctors are clamoring for more clarity on Paxlovid prescribing

NIH study of ME/CFS points to clear biological hallmarks

6 phony surgeries that take placebo to the extreme

Slovenia has suffered its worst

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

Pennsylvania man bitten on the head by bear during attack in his garage

explore

hotspot

focus

focus